Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that left investors unimpressed.
Read more...
Hence then, the article about hims hers stock slipped as investors were left unimpressed with its new weight loss drug options was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options )
Also on site :
- Related Digital Announces Financing for $16 Billion Oracle Data Center Project in Saline Township, Michigan
- Labor & Employment Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against USP Sacramento, Inc., for Alleged Failure to Pay Accurate Wages
- Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market